Current Value
$48.191 Year Return
Current Value
$48.191 Year Return
Double maintains 3 strategies that include BBIO - BridgeBio Pharma, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ROIV | 45.41% | $7.91B | +1.13% | 0.00% |
XENE | 43.76% | $2.50B | -22.20% | 0.00% |
CRSP | 42.75% | $4.87B | -1.81% | 0.00% |
IONS | 42.11% | $6.77B | -10.55% | 0.00% |
SITE | 42.07% | $5.69B | -5.14% | 0.00% |
CYTK | 41.87% | $4.61B | -32.78% | 0.00% |
SYRE | 40.55% | $990.40M | -43.02% | 0.00% |
OC | 40.52% | $12.27B | -17.16% | 1.78% |
IDYA | 40.23% | $1.98B | -45.39% | 0.00% |
IMVT | 39.29% | $3.18B | -39.07% | 0.00% |
RXRX | 38.83% | $2.28B | -35.61% | 0.00% |
DHR | 38.76% | $141.52B | -19.69% | 0.60% |
BPMC | 38.75% | $8.37B | +8.22% | 0.00% |
DNLI | 38.74% | $2.13B | -37.03% | 0.00% |
HXL | 38.53% | $4.76B | -12.60% | 1.07% |
CRNX | 38.11% | $3.09B | -39.01% | 0.00% |
IRON | 38.04% | $2.00B | +17.29% | 0.00% |
JOE | 37.41% | $3.01B | -12.16% | 1.08% |
MDB | 37.36% | $16.47B | -20.20% | 0.00% |
RVMD | 37.28% | $7.15B | -16.59% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LITB | -14.34% | $25.36M | -69.22% | 0.00% |
CBOE | -11.71% | $24.71B | +36.77% | 1.07% |
VSA | -11.06% | $12.16M | +21.20% | 0.00% |
MO | -8.89% | $97.92B | +21.81% | 7.02% |
SAVA | -7.19% | $104.35M | -82.48% | 0.00% |
BTCT | -7.07% | $29.39M | +101.55% | 0.00% |
CME | -6.80% | $99.84B | +44.13% | 1.75% |
STG | -5.37% | $56.15M | +27.66% | 0.00% |
ED | -5.35% | $36.39B | +11.91% | 3.34% |
DFDV | -4.73% | $361.15M | +2,667.20% | 0.00% |
PHYS.U | -4.19% | - | - | 0.00% |
VZ | -3.57% | $175.31B | +1.94% | 6.53% |
K | -2.88% | $27.64B | +41.46% | 2.87% |
HUSA | -2.80% | $20.46M | -9.15% | 0.00% |
UUU | -2.76% | $7.33M | +132.47% | 0.00% |
PPC | -2.42% | $10.68B | +32.81% | 0.00% |
CPSH | -2.34% | $36.61M | +48.24% | 0.00% |
AWK | -2.22% | $27.95B | +5.15% | 2.18% |
FATBB | -1.87% | $47.67M | -15.39% | 10.47% |
T | -1.69% | $195.43B | +46.18% | 4.11% |
Finnhub
Sustained Normalization of Mineral Homeostasis in Autosomal Dominant Hypocalcemia Type 1: Results from a Phase 2 Study Over 42 Months of Encaleret Treatment RI Gafni1, IR...
Finnhub
Autosomal Dominant Hypocalcemia Type 1 or Type 2 : Baseline Characteristics of Pediatric Participants in the CLARIFY Disease Monitoring Study Benson M1, Padidela R2, Bacchetta J3,...
Yahoo
Rivian downgraded, PayPal upgraded: Wall Street's top analyst calls
Finnhub
CALIBRATE-PEDS: A Phase 2/3, Multicenter, Single-Arm, Open-Label Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants with Autosomal Dominant...
Finnhub
Presenter SpeechChristine Siu [Presentation]Presenter SpeechChristine Siu Good morning, and welcome to the BridgeBio webcast on our LGMD program. I think this video highlights our mission and why...
Yahoo
BridgeBio Pharma (BBIO) is likely to see a continuation of its share outperformance as sales of Attr
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XONE | -0.02% | $629.16M | 0.03% |
IBMP | -0.14% | $554.05M | 0.18% |
FMF | -0.24% | $161.67M | 0.95% |
CGSM | -0.28% | $725.21M | 0.25% |
XHLF | -0.34% | $1.73B | 0.03% |
COMT | 0.38% | $612.23M | 0.48% |
PSQA | -0.48% | $36.50M | 0.2% |
GBIL | 0.63% | $6.37B | 0.12% |
FMHI | -0.81% | $748.97M | 0.7% |
GSG | 1.01% | $1.01B | 0.75% |
GLTR | 1.09% | $1.45B | 0.6% |
DBC | 1.18% | $1.26B | 0.87% |
TBIL | 1.23% | $5.74B | 0.15% |
COM | 1.23% | $210.46M | 0.72% |
SPTS | 1.25% | $5.78B | 0.03% |
STPZ | 1.27% | $443.85M | 0.2% |
VTIP | 1.31% | $15.19B | 0.03% |
TFLO | 1.47% | $6.73B | 0.15% |
USCI | 1.54% | $243.61M | 1.07% |
DBO | -1.57% | $228.22M | 0.77% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 53.87% | $5.19B | 0.35% |
IBB | 49.86% | $5.59B | 0.45% |
PBE | 48.18% | $233.59M | 0.58% |
FBT | 47.86% | $1.05B | 0.54% |
GNOM | 46.54% | $45.27M | 0.5% |
ARKG | 46.34% | $1.10B | 0.75% |
PINK | 43.68% | $132.39M | 0.5% |
BBH | 43.54% | $345.62M | 0.35% |
IWO | 43.17% | $11.96B | 0.24% |
PTH | 43.12% | $97.64M | 0.6% |
QQQJ | 43.03% | $633.38M | 0.15% |
VHT | 42.74% | $15.49B | 0.09% |
FHLC | 42.64% | $2.46B | 0.084% |
VBK | 42.23% | $19.43B | 0.07% |
VTWO | 41.95% | $12.69B | 0.07% |
IWM | 41.78% | $67.25B | 0.19% |
ISCG | 41.55% | $696.78M | 0.06% |
SCHA | 41.52% | $17.85B | 0.04% |
ESML | 41.52% | $1.91B | 0.17% |
NUSC | 41.45% | $1.17B | 0.31% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -32.03% | $310.24M | 1.43% |
TAIL | -28.65% | $94.90M | 0.59% |
VIXY | -28.45% | $200.94M | 0.85% |
VIXM | -22.49% | $22.99M | 0.85% |
TPMN | -12.66% | $30.86M | 0.65% |
USDU | -8.63% | $129.88M | 0.5% |
FXY | -8.05% | $798.58M | 0.4% |
UUP | -6.88% | $183.22M | 0.77% |
IVOL | -6.37% | $341.06M | 1.02% |
SHYM | -5.65% | $355.87M | 0.35% |
CLIP | -5.27% | $1.51B | 0.07% |
CANE | -5.08% | $11.17M | 0.29% |
UGA | -4.74% | $75.20M | 0.97% |
GLDM | -4.58% | $15.87B | 0.1% |
KCCA | -4.47% | $109.01M | 0.87% |
USL | -4.14% | $43.14M | 0.85% |
OILK | -4.00% | $72.70M | 0.69% |
USO | -3.95% | $1.03B | 0.6% |
CTA | -3.89% | $1.07B | 0.76% |
BNO | -3.84% | $108.34M | 1% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
EA | -0.08% | $37.40B | +2.64% | 0.52% |
LRN | -0.15% | $5.88B | +92.28% | 0.00% |
EIX | 0.19% | $19.61B | -30.24% | 6.36% |
GFI | -0.20% | $21.69B | +51.82% | 2.28% |
EDSA | -0.26% | $15.45M | -48.11% | 0.00% |
ASPS | -0.32% | $150.77M | +23.72% | 0.00% |
HMY | -0.46% | $8.96B | +52.38% | 1.21% |
HIHO | 0.56% | $7.36M | -25.37% | 4.38% |
VHC | 0.88% | $74.47M | +193.32% | 0.00% |
INFA | 0.95% | $7.38B | -10.99% | 0.00% |
WTRG | 0.98% | $10.61B | -4.25% | 3.45% |
SYPR | -1.01% | $47.57M | +11.87% | 0.00% |
GSM | 1.02% | $815.56M | -25.17% | 1.26% |
FDP | -1.05% | $1.62B | +52.79% | 3.28% |
CEF | 1.15% | - | - | 0.00% |
AEM | 1.17% | $60.44B | +59.95% | 1.35% |
KR | 1.21% | $47.78B | +38.66% | 1.78% |
CIG.C | 1.25% | $2.59B | +19.25% | 0.00% |
BTI | 1.25% | $112.32B | +59.44% | 5.94% |
YORW | 1.40% | $465.85M | -17.75% | 2.68% |